Underlying Holdings Performance: IBHI.US's price is directly tied to the performance of the underlying biotechnology and healthcare companies it holds. Strong performance in these companies will typically drive the ETF's price higher.

Sector Sentiment: Investor sentiment towards the biotechnology and healthcare sectors significantly impacts IBHI.US. Positive outlooks lead to increased investment and higher prices, while negative views cause price declines.

Interest Rate Changes: Rising interest rates can negatively affect IBHI.US, as they increase borrowing costs for biotech firms and make bonds more attractive to investors.

Economic Conditions: Economic growth generally supports healthcare spending and biotech innovation, benefiting IBHI.US. Economic downturns can lead to reduced healthcare investment and lower ETF prices.

Regulatory Changes: Changes in regulations affecting drug pricing, FDA approvals, or healthcare policies can significantly influence the profitability of companies held by IBHI.US, thereby affecting its price.

Mergers and Acquisitions: Mergers and acquisitions within the biotech and healthcare industries can cause price volatility in individual stocks held by IBHI.US, ultimately affecting the ETF's price.